The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.
Johnson & Johnson is planning to separate its orthopedic business, which will operate as DePuy Synthes, according to an Oct. 14 news release. Namal Nawana, former executive chair and founder of ...
Johnson, nearly two years into his speakership, is taking a hard line in shutdown negotiations. Speaker Mike Johnson insists ...
Johnson & Johnson reported third-quarter sales of $24 billion, beating the FactSet consensus estimate of $23.8 billion.
Jamison Private Wealth Management, Inc. disclosed a purchase of Johnson & Johnson shares valued at $6,762,412 in its SEC ...
MarketBeat on MSN
Johnson & Johnson's M&A Strategy Is the Real Story for Investors
Recent market speculation linking Johnson & Johnson (NYSE: JNJ) to a complete acquisition of its partner, Protagonist ...
Following an external search, the company selected Christopher DelOrefice, who will begin his tenure on Dec. 5; Chris Lialios ...
5don MSN
Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff
Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback